|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.660 USD | -0.21% |
|
-.--% | +3.10% |
| 04-15 | Evotec Taps CureVac Executive as COO | MT |
| 01-06 | CureVac ends coverage after BioNTech acquisition |  |
| Market Cap | 867M 999M 799M 749M 1.4B 95.65B 1.43B 9.53B 3.69B 46.11B 3.75B 3.67B 160B | P/E Ratio 2026 * |
-
| P/E Ratio 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 424M 489M 391M 366M 684M 46.79B 699M 4.66B 1.81B 22.56B 1.83B 1.8B 78.43B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CureVac
| 1 day | -0.21% | ||
| 6 months | -8.81% | ||
| Current year | +3.10% |
| Current year | 4.48 |  | 4.68 |
| 1 year | 4 | | 5.72 |
| 3 years | 2.22 | | 12.36 |
| 5 years | 2.22 | | 101.7 |
| 10 years | 2.22 | | 151.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 28/03/2023 | |
Myriam Mendila
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Malte Greune
COO | Chief Operating Officer | 61 | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/08/2015 | |
Mathias Hothum
BRD | Director/Board Member | 58 | 01/08/2015 |
Craig Tooman
BRD | Director/Board Member | 60 | 01/06/2019 |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -132M -153M -122M -114M -214M -14.61B -218M -1.46B -564M -7.04B -573M -560M -24.49B | - |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CVAC Stock
Select your edition
All financial news and data tailored to specific country editions
